Ebola may soon be a “preventable and treatable” disease after a trial of two drugs showed significantly improved survival rates.
Four drugs were tried on patients in the Democratic Republic of Congo, where there is a major outbreak of the virus.
Two of the drug were considerably more effective in treating the disease. Health officials say the drugs will now be used to treat all Ebola patients in D.R. Congo.
The US National Institute of Allergy and Infectious Diseases (NIAID), which co-sponsored the trial, said the results are “very good news” for the fight against Ebola.
The drugs work by attacking the Ebola virus with antibodies, neutralising its impact on human cells.